Treace Medical Valuation
| TMCI Stock | USD 7.83 0.11 1.39% |
At this time, the company appears to be overvalued. Treace Medical Concepts has a current Real Value of $7.21 per share. The regular price of the company is $7.83. Our model measures the value of Treace Medical Concepts from inspecting the company fundamentals such as Operating Margin of (0.34) %, shares outstanding of 62.3 M, and Return On Equity of -0.51 as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Treace Medical's valuation include:
Price Book 4.7151 | Enterprise Value 482 M | Enterprise Value Ebitda (40.95) | Price Sales 2.4383 | Enterprise Value Revenue 2.3758 |
Overvalued
Today
Please note that Treace Medical's price fluctuation is moderately volatile at this time. Calculation of the real value of Treace Medical Concepts is based on 3 months time horizon. Increasing Treace Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Treace Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Treace Stock. However, Treace Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 7.83 | Real 7.21 | Target 22.83 | Hype 7.94 | Naive 7.2 |
The intrinsic value of Treace Medical's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Treace Medical's stock price.
Estimating the potential upside or downside of Treace Medical Concepts helps investors to forecast how Treace stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Treace Medical more accurately as focusing exclusively on Treace Medical's fundamentals will not take into account other important factors: When choosing an evaluation method for Treace Medical Concepts, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
Treace Medical Cash |
|
Treace Valuation Trend
Treace Medical's real value analysis enables investors to forecast the earnings more efficiently. Using both Treace Medical's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing decisions.
Treace Medical Total Value Analysis
Treace Medical Concepts is at this time forecasted to have valuation of 481.96 M with market capitalization of 494.64 M, debt of 70.3 M, and cash on hands of 101.53 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Treace Medical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
481.96 M | 494.64 M | 70.3 M | 101.53 M |
Treace Medical Investor Information
About 25.0% of the company outstanding shares are owned by corporate insiders. The book value of Treace Medical was at this time reported as 1.69. The company recorded a loss per share of 0.99. Treace Medical Concepts had not issued any dividends in recent years. Based on the analysis of Treace Medical's profitability, liquidity, and operating efficiency, Treace Medical Concepts is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Treace Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Treace Medical has an asset utilization ratio of 74.28 percent. This signifies that the Company is making $0.74 for each dollar of assets. An increasing asset utilization means that Treace Medical Concepts is more efficient with each dollar of assets it utilizes for everyday operations.Treace Medical Ownership Allocation
Treace Medical Concepts shows a total of 62.3 Million outstanding shares. Over half of Treace Medical's outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Treace Medical Profitability Analysis
The company reported the previous year's revenue of 187.12 M. Net Loss for the year was (49.53 M) with profit before overhead, payroll, taxes, and interest of 114.31 M.About Treace Medical Valuation
An absolute valuation paradigm, as applied to Treace Stock, attempts to find the value of Treace Medical Concepts based on its fundamental and basic technical indicators. By analyzing Treace Medical's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Treace Medical's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Treace Medical. We calculate exposure to Treace Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Treace Medical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 151.9 M | 92.3 M | |
| Pretax Profit Margin | (0.26) | (0.28) | |
| Operating Profit Margin | (0.27) | (0.29) | |
| Net Loss | (0.26) | (0.28) | |
| Gross Profit Margin | 0.81 | 0.64 |
Treace Medical Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 60.9 M |
Treace Medical Current Valuation Indicators
Valuation refers to the process of determining the present value of Treace Medical Concepts and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Treace we look at many different elements of the entity such as Treace's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Treace Medical, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Treace Medical's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Treace Medical's worth.Complementary Tools for Treace Stock analysis
When running Treace Medical's price analysis, check to measure Treace Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Treace Medical is operating at the current time. Most of Treace Medical's value examination focuses on studying past and present price action to predict the probability of Treace Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Treace Medical's price. Additionally, you may evaluate how the addition of Treace Medical to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |